🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Metformin Single Tablet

Found 408 matching trials

Effect of Adding Metformin to Insulin in Uncontrolled Diabetic Patients During the 3rd Trimester of Pregnancy

PHASE4

Background Diabetes mellitus (DM) is a significant contributor to adverse o...

Status

Completed

Location

Cairo University

Start Date

2022-07-29

Trial ID

NCT05479214

Treatments Being Tested

Metformin Insulin

Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants

PHASE1

The purpose of this study is to evaluate the bioequivalence of metformin co...

Status

Completed

Location

Multiple Locations

Start Date

2014-08

Trial ID

NCT02221180

Treatments Being Tested

Canagliflozin and Metformin Immediate Release (IR) Fixed Dose Combination [FDC]Canagliflozin Metformin

Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)

PHASE3

This study will examine the safety and efficacy of the addition of sitaglip...

Status

Completed

Location

Multiple Locations

Start Date

2009-04-15

Trial ID

NCT00885352

Treatments Being Tested

Sitagliptin Comparator: Placebo Pioglitazone Metformin Glipizide

Bioequivalence Study for Acarbose / Metformin FDC

PHASE1

To establish the bioequivalence between Acarbose / Metformin FDC (50mg / 50...

Status

Completed

Location

Multiple Locations

Start Date

2012-09

Trial ID

NCT01728740

Treatments Being Tested

Acarbose/Metformin FDC (BAY81-9783)Acarbose (Glucobay, BAYG5421)Metformin

A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.

PHASE1

Bioequivalence study for the fixed-dose combination of Gemigliptin/Dapaglif...

Status

Completed

Location

Jeonbuk National University Hospital

Start Date

2026-01-09

Trial ID

NCT07399470

Treatments Being Tested

Test drug: Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg Reference drug: Gemigliptin (Zemiglo) 50mg, Dapagliflozin/metformin (Xigduo XR) 10/1000 mg

A Study to Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

PHASE1

The purpose of this study is to evaluate the bioequivalence of a fixed dose...

Status

Completed

Location

Multiple Locations

Start Date

2011-09

Trial ID

NCT01463228

Treatments Being Tested

A (canagliflozin and metformin IR individual tablets) / B (canagliflozin/metformin IR FDC tablets)B (canagliflozin/metformin IR FDC tablets / A (canagliflozin and metformin IR individual tablets)

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg

PHASE1

To compare the pharmacokinetic characteristics between HCP1201 tablet 750/1...

Status

Completed

Location

Samsung Medical Center

Start Date

2013-12

Trial ID

NCT02026817

Treatments Being Tested

HCP1201 750/10mg Metformin SR 750mg Rosuvastatin 10mg

PK and Relative Bioavailability of Liquid Metformin vs Tablets in Healthy Adults

PHASE1

The study will evaluate the pharmacokinetics and relative bioavailability o...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-03-15

Trial ID

NCT07300007

Treatments Being Tested

Liquid Metformin 100 mg/mL Liquid Metformin 250 mg/mL

Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.

PHASE1

\[Objectives\]Primary: To determine and compare the rate and extent of abso...

Status

Unknown

Location

Multiple Locations

Start Date

2019-11-01

Trial ID

NCT04050098

Treatments Being Tested

gemigliptin 50 mg and metformin hydrochloride 1000 mg prolonged release Gemigliptin tartrate sesquihydrate and metformin

A Pharmacokinetic and Pharmacodynamic Study of Metformin and Canagliflozin in Healthy Adult Volunteers

PHASE1

The purpose of the study is to investigate the potential interaction betwee...

Status

Completed

Location

Multiple Locations

Start Date

2010-12

Trial ID

NCT01273571

Treatments Being Tested

Canagliflozin/Metformin

Previous Next